SageView Advisory Group LLC Takes $2.33 Million Position in Ardent Health, Inc. $ARDT

Key Points

• SageView Advisory Group LLC acquired a new stake in Ardent Health, Inc. worth approximately $2.33 million, acquiring 169,233 shares in the first quarter.
• Other institutional investors, including Vanguard Group and Goldman Sachs, significantly increased their holdings in Ardent Health during the same period.
• Ardent Health reported $0.52 earnings per share for the recently completed quarter, exceeding analyst expectations, with an outlook for FY 2025 set at 1.730-2.01 EPS.

SageView Advisory Group LLC acquired a new stake in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 169,233 shares of the company's stock, valued at approximately $2,327,000. SageView Advisory Group LLC owned 0.12% of Ardent Health as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Ardent Health by 368.9% in the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock worth $18,296,000 after buying an additional 1,046,845 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after acquiring an additional 724,841 shares during the period. Nuveen LLC acquired a new position in shares of Ardent Health during the first quarter valued at about $6,010,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Ardent Health during the 1st quarter worth approximately $2,886,000. Finally, Walleye Capital LLC bought a new position in shares of Ardent Health during the 1st quarter worth about $1,831,000.

Ardent Health Stock Performance

NYSE:ARDT opened at $13.50 on Wednesday. The company has a market capitalization of $1.93 billion, a P/E ratio of 7.46, a P/E/G ratio of 5.97 and a beta of 0.30. Ardent Health, Inc. has a 1 year low of $10.10 and a 1 year high of $20.72. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00. The business has a fifty day simple moving average of $12.33 and a two-hundred day simple moving average of $13.16.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, analysts expect that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ARDT shares. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Stephens reissued an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. Wall Street Zen upgraded Ardent Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. KeyCorp reduced their price target on Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $21.00 target price on shares of Ardent Health in a research report on Thursday, May 15th. Eight equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $19.56.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.